These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3221434)

  • 41. Rokitamycin uptake by alveolar macrophages.
    Tasaka Y; Sumi M; Niki Y; Soejima R
    Jpn J Antibiot; 1988 Jul; 41(7):836-40. PubMed ID: 3172457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical results of 9, 3"-diacetylmidecamycin dry syrup in the pediatric field (author's transl)].
    Takimoto M; Oki J; Yoshioka H; Takase A; Nagamatsu I
    Jpn J Antibiot; 1982 Mar; 35(3):766-9. PubMed ID: 6980294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of Rokitamycin dry syrup in cases of upper deep cervical lymphadenitis and otitis media with exudatives].
    Mukai S; Mukai C; Asaoka K; Murakami S; Suzuki I
    Kansenshogaku Zasshi; 1989 Feb; 63(2):98-102. PubMed ID: 2501435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Chida T; Nakaya R
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study on susceptibilities of freshly isolated strains to macrolide antibiotics].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Dec; 43(12):2133-41. PubMed ID: 2086825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies of isolated organisms from otorhinolaryngological infections and their susceptibilities to macrolide antibiotics].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Sugita R; Fujimaki Y; Sanbe B; Ogura S
    Jpn J Antibiot; 1985 May; 38(5):1355-67. PubMed ID: 3930804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacokinetic and clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Sakata Y; Fujimoto T; Yokochi K; Yamashita F
    Jpn J Antibiot; 1989 Jul; 42(7):1629-66. PubMed ID: 2681864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on concentrations in body fluids of 16-membered ring macrolide antibiotics upon oral administration to healthy volunteers. Effects of their metabolites on bioassay values].
    Suzuki T; Sakai A; Morishita M; Ishioka T; Shimizu K
    Jpn J Antibiot; 1988 May; 41(5):510-22. PubMed ID: 3216473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of rokitamycin on upper gastrointestinal contractile activity. Analysis of side-effects on gastrointestinal tract].
    Itoh Z
    Jpn J Antibiot; 1988 Jul; 41(7):823-9. PubMed ID: 3172455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
    Iwai N; Nakamura H; Miyazu M; Watanabe Y
    Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
    Kanamoto Y; Miyake Y; Suginaka H; Usui T
    Chemotherapy; 1991; 37(4):256-9. PubMed ID: 1790724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.
    Maizumi N; Tamura Y; Kanai H; Tsutsui T
    J Periodontal Res; 2002 Aug; 37(4):250-4. PubMed ID: 12200967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experience with the use of 9,3"-diacetylmidecamycin dry syrup in pediatrics].
    Kobayashi Y; Haruta T; Kuroki S; Ohkura K
    Jpn J Antibiot; 1982 May; 35(5):1207-11. PubMed ID: 6982351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical studies of 9, 3"-diacetylmidecamycin (author's transl)].
    Sugaya N; Namba M; Okimoto Y; Nakamura A; Terashima I; Uehara S
    Jpn J Antibiot; 1982 Mar; 35(3):754-60. PubMed ID: 6980292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Laboratory and clinical studies on clarithromycin in pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Feb; 42(2):264-79. PubMed ID: 2526242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical studies on cefpodoxime proxetil dry syrup in the field of pediatrics].
    Haruta T; Kuroki S; Hashimoto N; Suzuki N; Okura K; Kobayashi Y
    Jpn J Antibiot; 1989 Jul; 42(7):1621-8. PubMed ID: 2562790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Laboratory and clinical studies of clarithromycin in pediatric fields].
    Nishimura T; Tabuki K; Aoki S; Takagi M
    Jpn J Antibiot; 1989 Feb; 42(2):353-69. PubMed ID: 2526248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bacteriological, pharmacokinetic and clinical studies on cefpodoxime proxetil in the pediatric field].
    Kimura H; Takeuchi H; Ishikawa H; Hayakawa F; Yamamoto N; Nakao Y; Kuno K
    Jpn J Antibiot; 1989 Jul; 42(7):1593-606. PubMed ID: 2562789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical results of 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)].
    Shinozaki T; Meguro H; Koike Y; Hashira S; Fujii R
    Jpn J Antibiot; 1982 Jan; 35(1):251-60. PubMed ID: 6978413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.